Guardian Pharmacy Services vs Progyny
Guardian Pharmacy Services reported revenue of $1.4 billion in fiscal 2025, about the same as Progyny's $1.3 billion in fiscal 2025. Guardian Pharmacy Services' revenue grew 17.9% in its latest year, and Progyny's grew 10.4%. Guardian Pharmacy Services had an operating margin of 5.0%, against 6.6% at Progyny. Free cash flow was $87 million at Guardian Pharmacy Services and $192 million at Progyny.
Side by side
| Guardian Pharmacy Services | Progyny | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $1.4B | $1.3B |
| Revenue growth | 17.9% | 10.4% |
| Revenue growth a year, last 5 years | — | 30.2% |
| Gross margin | 20.2% | 23.6% |
| Operating margin | 5.0% | 6.6% |
| Net margin | 3.4% | 4.5% |
| Free cash flow | $87M | $192M |
| Free cash flow margin | 6.0% | 14.9% |
| Return on capital | 31.0% | — |
| Net debt to EBITDA | −0.6x | — |
| Dividends and buybacks | $0M | $82M |
| Change in diluted share count | — | −5.8% |
| Last close | $49.52 | $36.18 |
| P/E at the last close | — | 33.2× |
| Insider trades, last 12 months | bought $99,786, sold $207.3 million | sold $24.1 million |
| Piotroski F-score | — | — |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
Guardian Pharmacy ServicesProgyny
Operating margin
Percent of revenue
Guardian Pharmacy ServicesProgyny
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Guardian Pharmacy ServicesProgyny
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Guardian Pharmacy Services and Progyny pages.